Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 13 studies | 32% ± 14% | |
ciliated cell | 12 studies | 38% ± 19% | |
endothelial cell | 11 studies | 27% ± 12% | |
smooth muscle cell | 10 studies | 31% ± 15% | |
basal cell | 8 studies | 30% ± 16% | |
pericyte | 8 studies | 38% ± 14% | |
astrocyte | 8 studies | 30% ± 18% | |
B cell | 7 studies | 21% ± 4% | |
connective tissue cell | 7 studies | 40% ± 25% | |
neuron | 7 studies | 51% ± 28% | |
epithelial cell | 7 studies | 50% ± 26% | |
oligodendrocyte precursor cell | 6 studies | 34% ± 16% | |
abnormal cell | 5 studies | 29% ± 5% | |
goblet cell | 5 studies | 25% ± 12% | |
mesothelial cell | 5 studies | 59% ± 26% | |
myofibroblast cell | 5 studies | 41% ± 13% | |
classical monocyte | 4 studies | 19% ± 3% | |
enteroendocrine cell | 4 studies | 38% ± 19% | |
glutamatergic neuron | 4 studies | 40% ± 17% | |
endothelial cell of lymphatic vessel | 4 studies | 33% ± 17% | |
macrophage | 4 studies | 24% ± 4% | |
natural killer cell | 4 studies | 19% ± 3% | |
retina horizontal cell | 4 studies | 29% ± 13% | |
memory B cell | 4 studies | 18% ± 2% | |
oligodendrocyte | 4 studies | 26% ± 9% | |
plasmacytoid dendritic cell | 4 studies | 20% ± 5% | |
hematopoietic precursor cell | 3 studies | 26% ± 7% | |
respiratory goblet cell | 3 studies | 22% ± 9% | |
secretory cell | 3 studies | 25% ± 7% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
conventional dendritic cell | 3 studies | 24% ± 5% | |
epithelial cell of proximal tubule | 3 studies | 19% ± 4% | |
neural crest cell | 3 studies | 46% ± 14% | |
progenitor cell | 3 studies | 44% ± 24% | |
vein endothelial cell | 3 studies | 31% ± 13% | |
brush cell | 3 studies | 25% ± 7% | |
club cell | 3 studies | 31% ± 12% | |
immature B cell | 3 studies | 23% ± 4% | |
pro-B cell | 3 studies | 30% ± 9% | |
type I pneumocyte | 3 studies | 36% ± 13% | |
amacrine cell | 3 studies | 42% ± 14% | |
Mueller cell | 3 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 36% ± 13% | |
group 3 innate lymphoid cell | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5246.76 | 258 / 258 | 100% | 30.52 | 230 / 230 |
esophagus | 100% | 2473.82 | 1445 / 1445 | 100% | 19.33 | 183 / 183 |
ovary | 100% | 5048.94 | 180 / 180 | 100% | 31.93 | 430 / 430 |
brain | 100% | 3866.61 | 2640 / 2642 | 100% | 25.13 | 705 / 705 |
prostate | 100% | 4476.21 | 245 / 245 | 100% | 30.13 | 501 / 502 |
uterus | 100% | 4070.95 | 170 / 170 | 100% | 23.41 | 458 / 459 |
thymus | 100% | 4057.56 | 653 / 653 | 100% | 21.45 | 603 / 605 |
intestine | 100% | 2964.23 | 966 / 966 | 100% | 18.29 | 525 / 527 |
liver | 100% | 1774.91 | 226 / 226 | 100% | 12.64 | 404 / 406 |
pancreas | 100% | 1840.20 | 328 / 328 | 99% | 19.47 | 177 / 178 |
skin | 100% | 2416.57 | 1808 / 1809 | 99% | 16.93 | 469 / 472 |
stomach | 100% | 2432.60 | 359 / 359 | 99% | 17.98 | 284 / 286 |
bladder | 100% | 2938.14 | 21 / 21 | 99% | 21.63 | 500 / 504 |
breast | 100% | 2670.22 | 459 / 459 | 99% | 18.50 | 1109 / 1118 |
kidney | 100% | 3050.09 | 89 / 89 | 99% | 14.81 | 893 / 901 |
lung | 100% | 2308.11 | 576 / 578 | 99% | 15.45 | 1142 / 1155 |
adipose | 100% | 2263.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 16.18 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.52 | 29 / 29 |
muscle | 100% | 2972.66 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2884.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.92 | 1 / 1 |
blood vessel | 100% | 2395.65 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2107.13 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1487.71 | 899 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005667 | Cellular component | transcription regulator complex |
Gene name | PTOV1 |
Protein name | Prostate tumor-overexpressed gene 1 protein PTOV1 extended AT-hook containing adaptor protein Prostate tumor-overexpressed gene 1 protein (PTOV-1) (Activator interaction domain-containing protein 2) |
Synonyms | ACID2 hCG_2039824 PP642 UNQ6127/PRO20092 |
Description | FUNCTION: May activate transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . FUNCTION: Activates transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation. . |
Accessions | ENST00000600793.1 M0QYH6 ENST00000599732.5 [Q86YD1-1] M0QYH7 M0QY25 ENST00000601675.5 [Q86YD1-1] ENST00000391842.6 [Q86YD1-1] ENST00000601093.5 A0A0C4DGR2 ENST00000601612.5 ENST00000597730.1 ENST00000594151.5 M0QX53 M0QYQ4 ENST00000600603.5 B4DG17 ENST00000601638.5 Q86YD1 M0QZB9 |